BARCLAYS PLC - POINT BIOPHARMA GLOBAL INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q3 2023$949
-9.0%
142,257
+23.5%
0.00%0.0%
Q2 2023$1,043
+41.9%
115,227
+14.1%
0.00%
Q1 2023$735
-43.5%
100,958
-43.4%
0.00%
-100.0%
Q4 2022$1,301
-99.8%
178,498
+88.3%
0.00%0.0%
Q3 2022$733,000
+531.9%
94,803
+453.5%
0.00%
Q2 2022$116,000
+7.4%
17,129
+26.2%
0.00%
Q1 2022$108,00013,5780.00%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q4 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,560,984$27,526,0006.63%
Fairmount Funds Management LLC 2,833,950$21,906,0003.85%
JOHNSON & JOHNSON 1,000,000$7,730,0002.28%
BVF INC/IL 5,590,048$43,211,0001.78%
Affinity Asset Advisors, LLC 746,576$5,771,0001.61%
Sio Capital Management, LLC 544,545$4,209,0001.34%
PFM Health Sciences, LP 4,515,216$34,903,0001.26%
SPHERA FUNDS MANAGEMENT LTD. 1,052,842$8,138,0001.13%
Boxer Capital, LLC 2,500,000$19,325,0001.09%
SILVERARC CAPITAL MANAGEMENT, LLC 300,000$2,319,0000.78%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders